Consultancy firm IDEA Pharma has released what it calls a ‘Productive Innovation Index’, which ranks pharmaceutical companies based on their ability to successfully commercialize new innovations.
Stephanie Sutton
Advertisement
Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.
Articles by Stephanie Sutton
The European Commission claims that Johnson & Johnson and Novartis may have breached European antitrust rules.
GlaxoSmithKline has entered into an agreement to purchase Shenzhen Neptunus? stake in a previously formed joint venture between the companies involved in the development and manufacture of influenza vaccines in China, Hong Kong, and Macau.
A European pilot initiative will test the impact of consultations with a number of stakeholders such as patient representatives and payers on early stage drug development.
August 20, 2010.
August 2, 2010.
August 01, 2010. French pharma giant accused of providing "misleading" and "incorrect" information.
July 10, 2010.
May 24, 2010.
April 29, 2010.
April 21, 2010.
April 21, 2010.
February 26, 2010.
Advertisement
Latest Updated Articles
- GSK Expands Vaccine Presence in China
Published: June 16th 2011 | Updated:
- Report Predicts Major Slowdown for Big Pharma
Published: March 4th 2010 | Updated:
- EU Generic Applications Down
Published: August 19th 2010 | Updated:
- Sanofi Fights FDA Approval of Generic Lovenox
Published: July 30th 2010 | Updated:
- Positive Outlook for UK Biotech Jobs
Published: February 25th 2010 | Updated:
- Servier Back in EC's Anticompetitive Behaviour Spotlight
Published: July 30th 2010 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
4
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
5
